We are analyzing https://link.springer.com/article/10.1007/s11897-013-0156-6.

Title:
Biological and Analytical Variation of Clinical Biomarker Testing: Implications for Biomarker-guided Therapy | Current Heart Failure Reports
Description:
Testing for serum-based biomarkers are essential for diagnosis, risk stratification, and management of patients with cardiovascular disease. All biomarker assays have inherent analytical variability (coefficient of variance CVA), ranging from 5–20 %. There are also variances within a subject over time (CVI) and between subjects (CVG). Variances are determined by experimentation under controlled conditions on healthy subjects. Once measured, the index of individuality (II), reference change value (RCV), and number of samples to establish a homeostatic set point can be calculated. These attributes affect how results of biomarker tests are interpreted in routine clinical practice such as cardiac troponin for acute coronary syndromes, the natriuretic peptides, galectin-3 and sST2 for heart failure, lipids and lipoproteins for primary cardiovascular disease risk, and liver function tests and skeletal muscle biomarkers for detecting complications from statin use.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

article, google, scholar, clin, pubmed, troponin, biological, variation, heart, cas, cardiac, chem, failure, ahb, patients, assay, change, testing, biomarkers, acute, natriuretic, highsensitivity, analytical, disease, variability, privacy, cookies, content, data, clinical, biomarker, implications, risk, cardiovascular, subjects, results, coronary, access, wians, myocardial, infarction, information, publish, search, published, alan, assays, reference, practice, syndromes,

Topics {✒️}

month download article/chapter acute coronary syndromes travel/accommodations/meeting expenses long-term individual variation aha/cdc scientific statement b-type natriuretic peptide long-term biological variation b-type natriuretic peptides high-sensitivity cardiac troponin biomarker-guided therapy biomarkers long-term biological variability elevated c-reactive protein short-term biological variation full article pdf chronic heart failure congestive heart failure cardiovascular disease privacy choices/manage cookies high-sensitivity assays high-sensitivity troponin natriuretic peptide testing high-sensitivity assay serum-based biomarkers skeletal muscle biomarkers high intraindividual variation b-type probnp american heart association inherent analytical variability related subjects cardiac troponin assays article wu sensitive cardiac troponin test result variation c-reactive protein acute myocardial infarction biomarker-guided therapy check access instant access cardiac troponin testing animal subjects performed highly sensitive troponin european economic area homeostatic set point absolute cutoff concentration fokkema mr van der meer deal-hf study garcia-lario jv jupiter study group wu ahb

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Biological and Analytical Variation of Clinical Biomarker Testing: Implications for Biomarker-guided Therapy
         description:Testing for serum-based biomarkers are essential for diagnosis, risk stratification, and management of patients with cardiovascular disease. All biomarker assays have inherent analytical variability (coefficient of variance CVA), ranging from 5–20 %. There are also variances within a subject over time (CVI) and between subjects (CVG). Variances are determined by experimentation under controlled conditions on healthy subjects. Once measured, the index of individuality (II), reference change value (RCV), and number of samples to establish a homeostatic set point can be calculated. These attributes affect how results of biomarker tests are interpreted in routine clinical practice such as cardiac troponin for acute coronary syndromes, the natriuretic peptides, galectin-3 and sST2 for heart failure, lipids and lipoproteins for primary cardiovascular disease risk, and liver function tests and skeletal muscle biomarkers for detecting complications from statin use.
         datePublished:2013-09-15T00:00:00Z
         dateModified:2013-09-15T00:00:00Z
         pageStart:434
         pageEnd:440
         sameAs:https://doi.org/10.1007/s11897-013-0156-6
         keywords:
            Biological variation
            Analytical variation
            Heart failure
            Acute coronary syndromes
            Cardiovascular disease risk
            Cardiology
            Cardiac Surgery
            Vascular Surgery
            Internal Medicine
            Imaging / Radiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11897-013-0156-6/MediaObjects/11897_2013_156_Fig1_HTML.gif
         isPartOf:
            name:Current Heart Failure Reports
            issn:
               1546-9549
               1546-9530
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Alan H. B. Wu
               affiliation:
                     name:University of California, San Francisco, San Francisco General Hospital
                     address:
                        name:Department of Laboratory Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Biological and Analytical Variation of Clinical Biomarker Testing: Implications for Biomarker-guided Therapy
      description:Testing for serum-based biomarkers are essential for diagnosis, risk stratification, and management of patients with cardiovascular disease. All biomarker assays have inherent analytical variability (coefficient of variance CVA), ranging from 5–20 %. There are also variances within a subject over time (CVI) and between subjects (CVG). Variances are determined by experimentation under controlled conditions on healthy subjects. Once measured, the index of individuality (II), reference change value (RCV), and number of samples to establish a homeostatic set point can be calculated. These attributes affect how results of biomarker tests are interpreted in routine clinical practice such as cardiac troponin for acute coronary syndromes, the natriuretic peptides, galectin-3 and sST2 for heart failure, lipids and lipoproteins for primary cardiovascular disease risk, and liver function tests and skeletal muscle biomarkers for detecting complications from statin use.
      datePublished:2013-09-15T00:00:00Z
      dateModified:2013-09-15T00:00:00Z
      pageStart:434
      pageEnd:440
      sameAs:https://doi.org/10.1007/s11897-013-0156-6
      keywords:
         Biological variation
         Analytical variation
         Heart failure
         Acute coronary syndromes
         Cardiovascular disease risk
         Cardiology
         Cardiac Surgery
         Vascular Surgery
         Internal Medicine
         Imaging / Radiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11897-013-0156-6/MediaObjects/11897_2013_156_Fig1_HTML.gif
      isPartOf:
         name:Current Heart Failure Reports
         issn:
            1546-9549
            1546-9530
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Alan H. B. Wu
            affiliation:
                  name:University of California, San Francisco, San Francisco General Hospital
                  address:
                     name:Department of Laboratory Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Current Heart Failure Reports
      issn:
         1546-9549
         1546-9530
      volumeNumber:10
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of California, San Francisco, San Francisco General Hospital
      address:
         name:Department of Laboratory Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Alan H. B. Wu
      affiliation:
            name:University of California, San Francisco, San Francisco General Hospital
            address:
               name:Department of Laboratory Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Laboratory Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(108)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

5.12s.

LINK . SPRINGER . COM {}